2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Motor Activity
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
910
Carboplatin
788
pembrolizumab
747
Paclitaxel
744
Bevacizumab
716
Cisplatin
709
Gemcitabine
621
Docetaxel
584
Rituximab
558
Radiotherapy
548
Dexamethasone
511
Nivolumab
491
Doxorubicin
445
Fluorouracil
392
Capecitabine
382
Etoposide
358
Pemetrexed
339
Cytarabine
335
Oxaliplatin
335
Lenalidomide
328
Prednisone
327
Erlotinib Hydrochloride
323
fludarabine phosphate
316
Trastuzumab
305
Leucovorin
299
fludarabine
296
Vincristine
288
Bortezomib
284
Filgrastim
284
Cetuximab
277
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Wearable Electronic Devices
×
Clear all
NCT04736576
2024-11-22
JBCRG-26
Pfizer
Phase NA
Completed
99 enrolled
47 charts